Joy Boy Myth :
add kezar on my watchlist, $富兰克林生物科技新领域基金 (LU0109394709.MF)$ is there... their return is crazy... not to mention $Kezar Life Sciences (KZR.US)$ CR is still 15... analyst target also high... That Evan McCulloch return isn't normal... 200% return over the years in biotech, that's crazy...
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week. Top Medical News of the Week Merck Q3 earnings top Wall Street’s expectations Merck stock surged within a buy zone Thursday after the pharma giant notched a third-quarter beat on particularly strong performances from Keytruda and Gardasil. Revenue from blockbuster cancer drug Keytruda soared 20% during the quarter, leading a ...
Gainers: •$Kezar Life Sciences(KZR.US)$+92% (announces positive top line results from the MISSION Phase 2 trial) •$Sutro Biopharma(STRO.US)$+24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates) •$Ceragon(CRNT.US)$+17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh) •$携程网(TCOM.US)$+15.6% (In reaction to earnings/guidance) •$Apyx Medical(APYX.US)$+8% (anno...
Kezar Life Sciences股票讨论区
He just sold
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences(KZR.US)$ ... for biotech...
recently he just sold.
If if if Lmdx really go crazy like how I predicted, this 2 ticker will go crazy as well
$Kezar Life Sciences(KZR.US)$
$LumiraDx(LMDX.US)$
🛫
good stock, maybe longer term hold
.
专栏Weekly FDA Drug Pipeline Calendar (Oct 31- Nov 4)
Top Medical News of the Week
Merck Q3 earnings top Wall Street’s expectations
Merck stock surged within a buy zone Thursday after the pharma giant notched a third-quarter beat on particularly strong performances from Keytruda and Gardasil.
Revenue from blockbuster cancer drug Keytruda soared 20% during the quarter, leading a ...
专栏Today's pre-market stock movers: TCOM, OXY, SAVE, GS and more
• $Kezar Life Sciences(KZR.US)$ +92% (announces positive top line results from the MISSION Phase 2 trial)
• $Sutro Biopharma(STRO.US)$ +24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates)
• $Ceragon(CRNT.US)$ +17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)
• $携程网(TCOM.US)$ +15.6% (In reaction to earnings/guidance)
• $Apyx Medical(APYX.US)$ +8% (anno...
专栏Today's pre-market stock movers: AMD, SBUX, ABNB, MRNA and more
• $Livent(LTHM.US)$ +22.58% (it posted better-than-expected quarterly earnings and raised its 2022 revenue forecast)
• $超微电脑(SMCI.US)$ +11.01% (earnings reports)
• $Oatly Group AB(OTLY.US)$ +8.31% (earnings reports)
• $布鲁林克斯(BXC.US)$ +9.7% (increases share repurchase authorization to $100 mln; enters into $60 mln accelerated repurchase agreement)
• $星巴克(SBUX.US)$ +7.18% (matched estimates wi...
暂无评论